Regeneron Pharmaceuticals (REGN) Net Margin Growth (5y) (2014 - 2026)

Regeneron Pharmaceuticals (REGN) Net Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,008.00
Mar 31, 2026 -2,393.00
Dec 31, 2025 -2,569.00
Sep 30, 2025 218.00
Jun 30, 2025 -811.00
Mar 31, 2025 -746.00
Dec 31, 2024 -1,828.00
Sep 30, 2024 -237.00
Jun 30, 2024 2,814.00
Mar 31, 2024 -1,064.00
Dec 31, 2023 -879.00
Sep 30, 2023 -578.00
Jun 30, 2023 -363.00
Mar 31, 2023 -576.00
Dec 31, 2022 118,614.00
Sep 30, 2022 1,893.00
Jun 30, 2022 345.00
Mar 31, 2022 192,813.00
Dec 31, 2021 2,438.00
Sep 30, 2021 2,557.00